Unknown

Dataset Information

0

Application of SARS-CoV-2 Serology to Address Public Health Priorities.


ABSTRACT: Background: Antibodies against SARS-CoV-2 can be detected by various testing platforms, but a detailed understanding of assay performance is critical. Methods: We developed and validated a simple enzyme-linked immunosorbent assay (ELISA) to detect IgG binding to the receptor-binding domain (RBD) of SARS-CoV-2, which was then applied for surveillance. ELISA results were compared to a set of complimentary serologic assays using a large panel of clinical research samples. Results: The RBD ELISA exhibited robust performance in ROC curve analysis (AUC> 0.99; Se = 89%, Sp = 99.3%). Antibodies were detected in 23/353 (6.5%) healthcare workers, 6/9 RT-PCR-confirmed mild COVID-19 cases, and 0/30 non-COVID-19 cases from an ambulatory site. RBD ELISA showed a positive correlation with neutralizing activity (p = <0.0001, R 2 = 0.26). Conclusions: We applied a validated SARS-CoV-2-specific IgG ELISA in multiple contexts and performed orthogonal testing on samples. This study demonstrates the utility of a simple serologic assay for detecting prior SARS-CoV-2 infection, particularly as a tool for efficiently testing large numbers of samples as in population surveillance. Our work also highlights that precise understanding of SARS-CoV-2 infection and immunity at the individual level, particularly with wide availability of vaccination, may be improved by orthogonal testing and/or more complex assays such as multiplex bead assays.

SUBMITTER: Sherman AC 

PROVIDER: S-EPMC8650110 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8083273 | biostudies-literature
| S-EPMC9725778 | biostudies-literature
| S-EPMC9676681 | biostudies-literature
| S-EPMC2732621 | biostudies-literature
| S-EPMC8386792 | biostudies-literature
| S-EPMC8008749 | biostudies-literature
| S-EPMC7302768 | biostudies-literature
| S-EPMC8013859 | biostudies-literature
| S-EPMC8239204 | biostudies-literature